MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited Total Current Liabilities 2011-2026 | BNR
Annual Total Current Liabilities Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 372 M | 242 M | 164 M | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 372 M | 164 M | 259 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medpace Holdings
MEDP
|
1.34 B | $ 460.74 | 0.83 % | $ 13.3 B |  USA |
 |
Bioventus
BVS
|
160 M | $ 9.15 | 1.67 % | $ 610 M | USA |
 |
Biodesix
BDSX
|
14.3 M | $ 15.54 | 5.79 % | $ 2.02 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.61 | -1.07 % | $ 427 M | USA |
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.39 | - | $ 417 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
8.34 B | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Personalis
PSNL
|
31.1 M | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
22.9 M | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 264.46 | 1.94 % | $ 26.1 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
10.6 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
RadNet
RDNT
|
587 M | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
3.14 M | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.66 | 0.6 % | $ 278 M | USA |
 |
Sotera Health Company
SHC
|
250 M | $ 13.84 | -0.32 % | $ 3.93 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 102.01 | -4.44 % | $ 4.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 31.34 | -1.2 % | $ 1.59 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
605 K | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Neuronetics
STIM
|
30.5 M | $ 1.46 | -9.06 % | $ 96.3 M | USA |
 |
Natera
NTRA
|
310 M | $ 194.52 | -2.78 % | $ 19.1 B | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 17.84 | 1.59 % | $ 951 M | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.13 | -1.74 % | $ 784 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 25.35 | -1.55 % | $ 704 M | USA |
 |
DarioHealth Corp.
DRIO
|
9.32 M | $ 7.76 | 3.47 % | $ 30.9 M | Israel |
 |
DexCom
DXCM
|
2.14 B | $ 66.6 | 1.0 % | $ 26 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | $ 104.91 | - | $ 19.8 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 47.49 | 6.72 % | $ 2.84 B | USA |